Prior gestational hyperglycemia: A long-term predictor of the metabolic syndrome
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Little is known about the association between prior gestational hyperglycemia of different severity and the subsequent risk for the metabolic syndrome. Eighty-one women with prior gestational diabetes mellitus (GDM), 25 with one abnormal value at the oral glucose tolerance test (OGTT), and 65 with normal OGTT were studied after a mean of 8.5 yr from the index pregnancy. Patients with prior gestational hyperglycemia (both one abnormal value at the OGTT and GDM) showed a worse metabolic pattern than subjects with gestational normoglycemia [respectively higher values of body mass index (BMI), waist, blood pressure, serum glucose, insulin, C-peptide, homeostatic model assessment (HOMA), fibrinogen and lower levels of HDL-cholesterol]. Prevalence of the metabolic syndrome and its components was 2-4-fold higher in women with prior gestational hyperglycemia (and 10-fold higher if pre-pregnancy obesity coexisted) when compared to normoglycemic controls; in a Cox proportional hazard model, after adjustments for age and pre-pregnancy BMI, gestational hyperglycemia and pre-pregnancy BMI predicted subsequent metabolic syndrome [respectively: hazard ratio (HR)=4.26 and HR=1.21] and most of its components. In the same model, the highest quartile of fasting serum glucose at the OGTT of the index pregnancy was significantly associated to the metabolic syndrome and its components. Gestational hyperglycemia and fasting glucose values were also associated to subsequent fibrinogen values, but not to albumin excretion rates. In young adult women, prior gestational hyperglycemia (particularly abnormal fasting glucose values), above all in combination with pre-pregnancy obesity, anticipates a subsequent syndrome at high cardiovascular risk and, possibly, a mild chronic inflammatory response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women who have had gestational diabetes are at high risk for the later development of impaired fasting glucose, impaired glucose tolerance, overt diabetes (91–93), and the metabolic syndrome (91, 94–106).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [95]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Ryckman, K., Spracklen, C., Smith, C., Robinson, J., & Saftlas, A. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13261 · Cited by 402
Thompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Song, C., Lyu, Y., Li, C., Liu, P., Li, J., Ma, R. C., & Yang, X. (2018) · Obesity Reviews · doi:10.1111/obr.12645 · Cited by 293
“Twenty five cohorts reported the diagnostic criteria for diabetes being used: 7 utilized the WHO’s 1985 criteria (17,18,22,23,33,39,44), 6 with the ADA’s (24,27,30,38,43,45), 5 used the WHO’s 1999 criteria (1999) (18,25,29,34,46), 4 used local or self-reported criteria (31,35,36,41), 1 with the National Diabetes Surve…”
BackgroundMethodObesity, gestational diabetes and pregnancy outcome
Yogev, Y., & Visser, G. H. A. (2009) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2008.09.002 · Cited by 283
Gestational Diabetes After Delivery
Kitzmiller, J. L., Dang-Kilduff, L., & Taslimi, M. M. (2007) · Diabetes Care · doi:10.2337/dc07-s221 · Cited by 171
Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087863 · Cited by 163
“Bo [26] prospective study 2004 Italy 17/81 3/65 Carpenter and Coustan NCEP-ATP III 8.”
BackgroundGunderson, E. P., Jacobs, D. R., Chiang, V., Lewis, C. E., Tsai, A., Quesenberry, C. P., & Sidney, S. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.03.031 · Cited by 138
Should we consider gestational diabetes a vascular risk factor?
Bo, S., Valpreda, S., Menato, G., Bardelli, C., Botto, C., Gambino, R., Rabbia, C., Durazzo, M., Cassader, M., Massobrio, M., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.017 · Cited by 117
Self-citationInflammatory Determinants of Pregravid Obesity in Placenta and Peripheral Blood
Sureshchandra, S., Marshall, N., Wilson, R. M., Barr, T., Rais, M., Purnell, J. Q., Thornburg, K. L. R., & Messaoudi, I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01089 · Cited by 92
“Power analysis was performed using GPower software using circulating levels of CRP from an earlier larger study (Caporaso et al., 2011), using differences between two independent means.”
MethodMaternal lipid profiles in women with and without gestational diabetes mellitus
Wang, J., Li, Z., & Lin, L. (2019) · Medicine · doi:10.1097/md.0000000000015320 · Cited by 110
“Women with GDM are at highly increased risk of developing metabolic diseases after pregnancy including hyperlipidemia, type 2 diabetes, and so on.([32,33]) There have been extensive studies about circulating lipid patterns in GDM vs normal pregnancy, with no consistent conclusions.”
BackgroundLappas, M., Mundra, P. A., Wong, G., Huynh, K., Jinks, D., Georgiou, H. M., Permezel, M., & Meikle, P. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3587-7 · Cited by 96
“5 years [7] after the index pregnancy.”
C‐reactive protein and metabolic syndrome in women with previous gestational diabetes
Di Cianni, G., Lencioni, C., Volpe, L., Ghio, A., Cuccuru, I., Pellegrini, G., Benzi, L., Miccoli, R., & Del Prato, S. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.661 · Cited by 84
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
Burlina, S., Dalfra, M., Chilelli, N. C., & Lapolla, A. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2070926 · Cited by 76
“1% in a control population [10–12].”
Albareda, M., Caballero, A., Badell, G., Rodríguez-Espinosa, J., Ordóñez‐Llanos, J., de Leiva, A., & Corcoy, R. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.017 · Cited by 72
“5 years [17].”
InfluentialPrediction of developing metabolic syndrome after gestational diabetes mellitus
Akıncı, B., Çeltik, A., Yener, S., & Yeşil, S. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.007 · Cited by 67
Kim, C., Cheng, Y. J., & Beckles, G. L. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31818638b5 · Cited by 51
“None 32 (2) 23 (12) 0 (0) 1–2 50 (2) 64 (13) 14 (6) More than 3 19 (2) 13 (5) 86 (6) Number of cardiovascular disease risk factors None 30 (2) 12 (6) 0 .”
InfluentialAkinci, B., Celtik, A., Genc, S., Yener, S., Demir, T., Secil, M., Kebapcilar, L., & Yesil, S. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.492885 · Cited by 46
“2% and 21% among women with previous GDM in the United States [8] and Europe [25], respectively.”
BackgroundInfluentialTranidou, A., Dagklis, T., Tsakiridis, I., Siargkas, A., Apostolopoulou, A., Mamopoulos, A., Goulis, D. G., & Chourdakis, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01464-6 · Cited by 43
Ali, H. I., Jarrar, A. H., Sadig, M. E., & Yeatts, K. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073486 · Cited by 49
“Moreover, although gestational diabetes usually resolves following birth, it is known to confer an increased risk for recurrent GDM in subsequent pregnancies, type 2 diabetes mellitus, and cardiovascular risk factors later in life [6,7].”
BackgroundHypertension in diabetic pregnancy: impact and long-term outlook
Colatrella, A., Loguercio, V., Mattei, L., Trappolini, M., Festa, C., Stoppo, M., & Napoli, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.003 · Cited by 42
Yefet, E., Schwartz, N., Sliman, B., Ishay, A., & Nachum, Z. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0881-6 · Cited by 43
Gestational diabetes mellitus screening and outcomes
Aktun, H. L., Uyan, D., Yorgunlar, B., & Acet, M. (2015) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2015.15081 · Cited by 38
“GDM usually resolves after delivery, but it appears that the risk of recurring GDM and type 2 diabetes mellitus are increased in subsequent pregnancies, along with cardiovascular risk later in life (10, 11).”
BackgroundMetabolic syndrome in women with previous gestational diabetes
Kaiser, K., Nielsen, M. F., Kallfa, E., Dubietyte, G., & Lauszus, F. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-90832-0 · Cited by 30
Shi, P., Tang, J., & Yin, X. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05630-5 · Cited by 39
“Discussion GDM, a common pregnancy complication, has been reported to be related to maternal dyslipidemia [33, 34].”
BackgroundNouhjah, S., Shahbazian, H. B., Shahbazian, N., Jahanfar, S., Jahanshahi, A., Cheraghian, B., Mohammadi, Z. D., Ghodrati, N., & Houshmandi, S. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.027 · Cited by 28
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes
Pleiner, J., Mittermayer, F., Langenberger, H., Winzer, C., Schaller, G., Pacini, G., Kautzky‐Willer, A., Tura, A., & Wolzt, M. (2007) · Wiener klinische Wochenschrift · doi:10.1007/s00508-007-0838-8 · Cited by 28
“These patients have a high risk of developing type 2 diabetes [9], despite normalization of hyperglycemia after delivery.”
BackgroundPuhkala, J., Kinnunen, T. I., Vasankari, T. J., Kukkonen-Harjula, K. T., Raitanen, J. A., & Luoto, R. M. (2013) · Journal of Pregnancy · doi:10.1155/2013/139049 · Cited by 32
“Hindawi Publishing Corporation Journal of Pregnancy Volume 2013, Article ID 139049, 7 pages http://dx.doi.org/10.1155/2013/139049”
BackgroundInfluentialMetabolic disorders during pregnancy and postpartum cardiometabolic risk
Patti, A. M., Pafili, K., Παπάνας, Ν., & Rizzo, M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0130 · Cited by 25
“GDM and obesity had relatively higher values of anthropometric parameters (such as body mass index [BMI] and waist circumference), blood pressure, glucose, homeostatic model assessment [HOMA], insulin, C-peptide and fibrinogen, together with lower HDL-C levels (9).”
BackgroundHackmon, R., James, R., Green, C. O., Ferber, A., Barnhard, Y. B., & Divon, M. Y. (2007) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050601135220 · Cited by 32
“In addition, obese women with GDM are more likely to develop the metabolic syndrome [14,15].”
BackgroundCardiovascular Disease in Women: Challenge of the Middle Years
Piña, I. L. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318209c233 · Cited by 28
Lappas, M., Jinks, D., Ugoni, A. M., Louizos, C. C., Permezel, M., & Georgiou, H. M. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12209 · Cited by 23
Ijäs, H., Morin-Papunen, L. C., Keränen, A. K., Bloigu, R., Ruokonen, A., Puukka, K. S., Ebeling, T., Raudaskoski, T., & Vääräsmäki, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0412 · Cited by 22
Nutrition for healthy pregnancy outcomes
Vause, T. D. R., Martz, P., Richard, F., & Gramlich, L. M. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-001 · Cited by 16
Zajdenverg, L., Rodacki, M., de Faria, J. P., Pires, M. L. E., de Oliveira, J. E. P., & Halfoun, V. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-63 · Cited by 17
“A few authors have shown that pGDM individuals, despite being currently free from metabolic abnormalities, have higher values of markers of endothelial dysfunction, such as E-selectin and intercellular adhesion molecule 1 or ICAM-1 [35], but there is not a consensus.”
BackgroundBarquiel, B., Herranz, L., Hillman, N., Burgos, M. Á., & Pallardo, L. F. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0153 · Cited by 18
Sedentary behavior, gestational diabetes mellitus, and type 2 diabetes risk: where do we stand?
Johnson, S. T., Lynch, B. M., Vallance, J. K., Davenport, M. H., Gardiner, P. A., & Butalia, S. (2016) · Endocrine · doi:10.1007/s12020-015-0828-y · Cited by 15
Metabolic Syndrome: Screening, Diagnosis, and Management
Miller, E. L., & Mitchell, A. (2006) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2006.01.007 · Cited by 21
Far, M. A., Ziaei, S., & Kazemnejad, A. (2012) · PubMed Central · Cited by 12
Li, W., Liu, H., Qiao, Y., Lv, F., Zhang, S., Wang, L., Leng, J., Liu, H., Qi, L., Tuomilehto, J. O., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12790 · Cited by 12
Mild Gestational Hyperglycemia and the Metabolic Syndrome in Later Life
Bo, S., Menato, G., Botto, C., Cotrino, I., Bardelli, C., Gambino, R., Cassader, M., Durazzo, M., Signorile, A., Massobrio, M., et al. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.113 · Cited by 13
Self-citationStanhewicz, A. E., Schlarmann, R. L., Brustkern, K. M., & Jalal, D. I. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00189.2022 · Cited by 14
GDM: Postpartum management to reduce long-term risks
Khandelwal, M. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0051-9 · Cited by 12
Winhofer, Y., Krššák, M., Wolf, P. S., Tura, A., Anderwald, C. H., Kosi, L., Reiter, G., Pacini, G., Trattnig, S., Luger, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091607 · Cited by 9
“Since pGDM exhibit many features of the Cardio-metabolic Syndrome, including hyperglycemia and hyperinsulinemia [15,16] we hypothesized that cardiac steatosis might present an early sign of cardiac vulnerability and can be detected in these women with impaired glucose tolerance and early diabetes.”
BackgroundSodhi, N. K., & Nelson, A. L. (2018) · Contraception and Reproductive Medicine · doi:10.1186/s40834-018-0080-y · Cited by 10
Metabolic syndrome after a pregnancy complicated by gestational diabetes
Madarász, E., Tamás, G., Tabák, Á. G., Szalay, J., & Kerényi, Z. (2008) · Orvosi Hetilap · doi:10.1556/oh.2008.28242 · Cited by 7
Gestational diabetes : long-term, metabolic consequences for the mother and child
Pirkola, J. (2010) · Cited by 9
Predictors of Postpartum Lipid Abnormalities in Women with Gestational Diabetes
Edwards, A. M., Meltzer, S., Rahme, E., & Dasgupta, K. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.10.003 · Cited by 4
Johnson, S. T., Mladenovic, A. B., Mathe, N., Davenport, M. H., Butalia, S., Qiu, W., & Johnson, J. A. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.008 · Cited by 6
Gestational Diabetes and the Metabolic Syndrome
Souza, L. R. D., Joël, G., & Retnakar, R. (2011) · InTech eBooks · doi:10.5772/22119 · Cited by 5
“This risk is 10 times higher in women with concomitant pre-pregnancy obesity (Bo et al., 2004a).”
InfluentialIDF-MENA Region Guidelines for Management of Hyperglycemia in Pregnancy
Masood, S. N., Shegem, N. S., Baqai, S. M., Suliman, M. T., Alromaihi, D., Sultan, M. T. H., Salih, B. T., Ram, U., Ahmad, Z., Al-Jufairi, Z. A., et al. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_58_21 · Cited by 4
The Perinatal Biopsychosocial Consequences of Various Levels of Gestational Hyperglycemia
Hung, C., Yu, C., & Huang, M. (2018) · Clinical Nursing Research · doi:10.1177/1054773818769210 · Cited by 2
Thompson, D. M., Berger, H. M., Feig, D. S., Gagnon, R. J., Kader, T., Keely, E., Kozak, S. E., Ryan, E. A., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.040 · Cited by 8
Castro-Dufourny, I., de la Morena, L. H., Borge, V. M., & Sánchez, L. F. P. (2009) · Revista Clínica Española · doi:10.1016/s0014-2565(09)70627-7 · Cited by 4
Mothers with HIP – The short term and long-term impact, what is new?
Mecacci, F., Ottanelli, S., & Petraglia, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.039 · Cited by 1
Maor‐Sagie, E., Hallak, M., Toledano, Y., & Gabbay‐Benziv, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186072 · Cited by 1
“…hyperglycemia is a continuum throughout pregnancy, and several studies have demonstrated increased fetal and maternal risk with increasing glucose levels even within the normal range [18,19], we need models with a longer follow-up time to determine the actual risk of late GDM and SAV diagnosis.”
BackgroundObesity Co‐Morbid Conditions in Pregnancy: Diabetes and Hypertension
Hadar, E., & Yogev, Y. (2011) · Wiley eBooks · doi:10.1002/9781444391183.ch11 · Cited by 1
Evaluación de las distintas estrategias diagnósticas para diabetes gestacional
Rodríguez, I. (2012) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Smoking: a modifiable risk factor for gestational diabetes? -a review
Ponnusha, B. S., Ambika, A., Pasupathi, P., & M.Essa, M. (2010) · Cited by 1
Molar Pregnancy with Viable Foetus Progressed to Term - Case Report
Tudy, C. S., & Article, C. (2013)
Njoku, C. M., Meludu, S., Onuegbu, J. A., Okafor, C., Osakue, N. O., & Onuora, J. I. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.27.1.2471
“…without such metabolic history, and these women with prior GDM and obesity had relatively higher values of anthropometric parameters (such as BMI and waist circumference), blood pressure, glucose, homeostatic model assessment, insulin, C-peptide and fibrinogen, together with lower HDL-C levels [8].”
Arcot, A., Gallagher, K., Goldstein, J. A., & Gernand, A. D. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101280
Metadata
- Authors
- Bo, S., Monge, L., Macchetta, C., Menato, G., Pinach, S., Uberti, B., & Pagano, G.
- Affiliations
- University of Turin (IT)
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- Corresponding author
- Bo, S.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2004-07
- Volume
- 27
- Issue
- 7
- Pages
- 629-635
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2090166556
- Cited by
- 63
- References
- 38
- Citations by year
- 2026: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 3
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- hyperglycemia in pregnancy, gestational diabetes mellitus, metabolic syndrome, pre-pregnancy obesity, long-term risk prediction, fasting blood glucose, oral glucose tolerance test, fibrinogen, chronic inflammation, cardiovascular risk, insulin resistance, HDL cholesterol, albuminuria
- MeSH terms
- Adult, Age Factors, Female, Fibrinogen, Glucose Tolerance Test, Humans, Inflammation, Male, Middle Aged, Obesity, Pregnancy, Risk Factors, Severity of Illness Index, Case-Control Studies, Diabetes, Gestational, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.